Skip to content

The effectivness of camel milk in autism spectrum disorders

The therapeutic possibilities of camel milk in autism spectrum disorders: a longitudinal interventional single-blinded single centre trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN87863054
Enrollment
60
Registered
2011-04-12
Start date
2011-01-10
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism spectrum disorders Mental and Behavioural Disorders Pervasive developmental disorders

Interventions

This project will be conducted on autistic children (60) with typical behavioural disorders (divided into 2 groups, group 1 will receive cold pasteurised camel milk, group 2 will receive boiled camel

Sponsors

King Abdul Aziz City for Science and Technology (KACST) (Saudi Arabia)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Children with autism spectrum disorders (ASD) confirmed by Autism Diagnostic Observation Schedule (ADOS) and Developmental, Dimensional and Diagnostic Interview (3DI) 2. Aged between 4 and 15 years, either sex 3. All simplex cases

Exclusion criteria

Exclusion criteria: 1. Fragile X gene study 2. Tuberous sclerosis 3. Angleman syndrome 4. Other serious neurological conditions (e.g., seizures) 5. Psychiatric (e.g., bipolar disorder) or known medical conditions

Design outcomes

Primary

MeasureTime frame
1. Less allergy 2. Increased attention 3. Increased concentration Outcomes assessed at baseline, 3 and 6 months, using the following tools: 1. Parent Questionnaire 2. Social Responsiveness Scale (SRS) 3. Childhood Autism Rating Scale (CARS) 4. Autism Treatment Evaluation Checklist (ATEC)

Secondary

MeasureTime frame
1. Improve general health 2. Improve social relation 3. Improve academic performance Outcomes measures immediately following intervention, and 3 and 6 months afterwards.

Countries

Saudi Arabia

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026